Cefdinir Capsule
Product Images NDC 65862-177

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cefdinir (NDC 65862-177). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel -300 mg (30 Capsule Bottle) (Cefdinir Fig1)

Label for Cefdinir Capsules USP 300 mg, packaged 30 capsules per bottle. The label indicates the drug is distributed by Aurobindo Pharma USA, Inc., with manufacturing in India. Storage instructions specify keeping the capsules at 20 to 25°C, protected from light, in tight containers. The label includes barcode and regulatory information, with directions to see the package insert for dosage details.*

FDA Label Image

Chemical Structure (Cefdinir Str)

Chemical structure of cefdinir, showing its molecular arrangement including beta-lactam and other characteristic rings and functional groups, as depicted in the diagram.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.